SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/01/17 Mimedx Group, Inc. 10-K 12/31/16 96:9.2M |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 885K 2: EX-3.1 Articles of Incorporation/Organization or Bylaws HTML 78K 3: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 91K 4: EX-21.1 Subsidiaries List HTML 25K 5: EX-23.1 Consent of Experts or Counsel HTML 27K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 33K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 33K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 28K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 28K 16: R1 Document and Entity Information HTML 53K 17: R2 Consolidated Balance Sheets HTML 115K 18: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K 19: R4 Consolidated Statements of Operations HTML 73K 20: R5 Consolidated Statements of Stockholders' Equity HTML 107K 21: R6 Consolidated Statements of Cash Flows HTML 113K 22: R7 Nature of Business HTML 30K 23: R8 Significant Accounting Policies HTML 72K 24: R9 Liquidity and Capital Resources HTML 31K 25: R10 Acquisition of Stability Inc. HTML 164K 26: R11 Cash Equivalents and Short Term Investments HTML 28K 27: R12 Inventories HTML 39K 28: R13 Property and Equipment HTML 44K 29: R14 Intangible Assets and Royalty Agreement HTML 70K 30: R15 Long-Term Debt HTML 32K 31: R16 Net Income Per Share HTML 57K 32: R17 Equity HTML 144K 33: R18 Income Taxes HTML 97K 34: R19 Supplemental Disclosure of Cash Flow and Non-Cash HTML 46K Investing and Financing Activities 35: R20 401k Plan HTML 31K 36: R21 Related Party Transactions HTML 31K 37: R22 Commitments and Contingencies HTML 66K 38: R23 Quarterly Financial Data (Unaudited) HTML 78K 39: R24 Product Revenue Data HTML 45K 40: R25 Subsequent Events HTML 28K 41: R26 Schedule II - Valuation and Qualifying Accounts HTML 73K 42: R27 Significant Accounting Policies (Policies) HTML 137K 43: R28 Acquisition of Stability Inc. (Tables) HTML 154K 44: R29 Inventories (Tables) HTML 40K 45: R30 Property and Equipment (Tables) HTML 41K 46: R31 Intangible Assets and Royalty Agreement (Tables) HTML 70K 47: R32 Net Income Per Share (Tables) HTML 68K 48: R33 Equity (Tables) HTML 142K 49: R34 Income Taxes (Tables) HTML 93K 50: R35 Supplemental Disclosure of Cash Flow and Non-Cash HTML 44K Investing and Financing Activities (Tables) 51: R36 Commitments and Contingencies (Tables) HTML 34K 52: R37 Quarterly Financial Data (Unaudited) (Tables) HTML 77K 53: R38 Product Revenue Data (Tables) HTML 39K 54: R39 Nature of Business (Details) HTML 27K 55: R40 Significant Accounting Policies (Details) HTML 53K 56: R41 Liquidity and Capital Resources (Details) HTML 40K 57: R42 Acquisition of Stability Inc. - Narrative HTML 74K (Details) 58: R43 Acquisition of Stability Inc. - Fair Value of HTML 40K Stock Consideration (Details) 59: R44 Acquisition of Stability Inc. - Preliminarily HTML 121K Allocation of Purchase Price (Details) 60: R45 Acquisition of Stability Inc. - Intangible Assets HTML 36K Acquired as Part of Acquisition (Details) 61: R46 Acquisition of Stability Inc. - Goodwill HTML 34K Reconciliation (Details) 62: R47 Acquisition of Stability Inc. - Measurement Period HTML 117K Adjustments (Details) 63: R48 Acquisition of Stability Inc. - Pro Forma HTML 32K Information (Details) 64: R49 Cash Equivalents and Short Term Investments HTML 32K (Details) 65: R50 Inventories (Details) HTML 40K 66: R51 Property and Equipment (Details) HTML 54K 67: R52 Intangible Assets and Royalty Agreement - HTML 98K Intangible Asssets Activity Summary (Details) 68: R53 Intangible Assets and Royalty Agreement - HTML 29K Narrative (Details) 69: R54 Intangible Assets and Royalty Agreement - Expected HTML 42K Future Amortization of Intangible Assets (Details) 70: R55 Long-Term Debt (Details) HTML 47K 71: R56 Net Income Per Share - Computation of Basic and HTML 50K Dilutive Net Loss per Share (Details) 72: R57 Net Income Per Share - Summary of Antidilutive HTML 38K Securities (Details) 73: R58 Equity - Narrative (Details) HTML 82K 74: R59 Equity - Activity of Stock Options (Details) HTML 80K 75: R60 Equity - Exercise Price Ranges (Details) HTML 77K 76: R61 Equity - Summary of Unvested Stock Options HTML 46K (Details) 77: R62 Equity - Assumptions (Details) HTML 45K 78: R63 Equity - Summary of Restricted Stock Awards HTML 51K (Details) 79: R64 Equity - Recognized Stock-Based Compensation HTML 36K (Details) 80: R65 Income Taxes - Deferred Tax Assets and Liabilities HTML 52K (Details) 81: R66 Income Taxes - Reconciliation of the Federal HTML 60K Statutory Income Tax (Details) 82: R67 Income Taxes - Schedule of current and deferred HTML 51K income tax expense (Benefit) (Details) 83: R68 Income Taxes - Narrative (Details) HTML 51K 84: R69 Income Taxes - Reconciliation of unrecognized tax HTML 31K benefits (Details) 85: R70 Supplemental Disclosure of Cash Flow and Non-Cash HTML 48K Investing and Financing Activities (Details) 86: R71 401k Plan (Details) HTML 38K 87: R72 Related Party Transactions (Details) HTML 34K 88: R73 Commitments and Contingencies - Narrative HTML 56K (Details) 89: R74 Commitments and Contingencies - Estimated Annual HTML 38K Lease, Royalty, and Employment Agreement Expenses (Details) 90: R75 Quarterly Financial Data (Unaudited) (Details) HTML 46K 91: R76 Product Revenue Data (Details) HTML 37K 92: R77 Subsequent Events (Details) HTML 33K 93: R78 Schedule II - Valuation and Qualifying Accounts HTML 42K (Details) 95: XML IDEA XML File -- Filing Summary XML 163K 94: EXCEL IDEA Workbook of Financial Reports XLSX 106K 10: EX-101.INS XBRL Instance -- mdxg-20161231 XML 2.32M 12: EX-101.CAL XBRL Calculations -- mdxg-20161231_cal XML 269K 13: EX-101.DEF XBRL Definitions -- mdxg-20161231_def XML 662K 14: EX-101.LAB XBRL Labels -- mdxg-20161231_lab XML 1.86M 15: EX-101.PRE XBRL Presentations -- mdxg-20161231_pre XML 1.11M 11: EX-101.SCH XBRL Schema -- mdxg-20161231 XSD 167K 96: ZIP XBRL Zipped Folder -- 0001376339-17-000042-xbrl Zip 257K
Exhibit |
Company | Jurisdiction of Organization |
MiMedx, Inc. | Florida |
MiMedx Processing Services, LLC | Florida |
MiMedx
Tissue Services, LLC | Georgia |
Stability Biologics, LLC | Georgia |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 12/17/20 Mimedx Group, Inc. S-8 12/17/20 5:422K Donnelley … Solutions/FA 11/04/20 Mimedx Group, Inc. 10-Q 9/30/20 79:7.4M 11/02/20 Mimedx Group, Inc. 8-A12B 1:37K 8/04/20 Mimedx Group, Inc. 10-Q 6/30/20 71:5.9M 3/20/17 SEC UPLOAD¶ 9/28/17 1:173K Mimedx Group, Inc. |